AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 22120913
Drug: Chronic transfusion
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic transfusion therapy
Trial: 10808175
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone (40 mg/day) for 9 days
Trial: 1325348
Drug: Phosphatidylserine 800
RxNorm normalized name: Phosphatidylserine
DrugBank: Phosphatidyl serine (DB00144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phosphatidylserine 800 mg/d for 10 days
Trial: 558548
Drug: Pindolol 15
RxNorm normalized name: pindolol 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol 15 mg daily
Trial: 6617682
Drug: Pindolol (for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol (for patients starting therapy later than 5 days after myocardial infarction)
Trial: 6617682
Drug: Pindolol (for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol (for patients starting therapy after 12 days)
Trial: 6617682
Drug: Pindolol (for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol (for patients on digitalis therapy)
Trial: 22324753
Drug: Multifaceted Group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multifaceted Group (MG; n = 73)
Trial: 18929280
Drug: Spinal anesthesia
RxNorm normalized name: Bos taurus spinal cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal anesthesia with 7.5 mg of 0.5% hyperbaric bupivacaine
Trial: 18929280
Drug: Combined sciatic-femoral
RxNorm normalized name: Sus scrofa temporal lobe preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined sciatic-femoral nerve blocks using a mixture of 20 mL of lidocaine 2% plus 20 mL of bupivacaine 0.5%
Trial: 12390617
Drug: Buccal placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buccal placebo
Trial: 12390617
Drug: Oral ergotamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ergotamine tartarate (ERG) 1 mg plus caffeine 100 mg
Trial: 30850957
Drug: CT-P16 5
RxNorm normalized name: CT-179
DrugBank: CT-179 (DB17114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CT-P16 5 mg/kg
Trial: 30850957
Drug: EU-bevacizumab 5
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: EU-bevacizumab 5 mg/kg
Trial: 30850957
Drug: US-bevacizumab 5
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: US-bevacizumab 5 mg/kg
Trial: 25600659
Drug: 1110 MBq
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1110 MBq I‐131 (low dose)
Trial: 25600659
Drug: 3700 MBq
RxNorm normalized name: dotatate
DrugBank: Dotatate (DB14554)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3700 MBq I‐131 (standard dose)
Trial: 17319338
Drug: Intraoperative intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoperative intravenous diclofenac (1 mg/kg i.v. after induction followed by an infusion of 1 mg/kg over 2 hours)
Trial: 10886272
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no oral isotretinoin)
Trial: 18273733
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine (Lantus) daily from start of surgery
Trial: 18273733
Drug: Regular insulin
RxNorm normalized name: Regular insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular insulin (Actrapid) when needed (sliding scale)
Trial: 12170023
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of methylprednisolone (10 mg/kg body weight) 30 minutes before surgery (MP group)
Trial: 23812272
Drug: Placebo infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo infusion (control group)
Trial: 12170023
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of methylprednisolone (MP group)
Trial: 10565450
Drug: Insulin-dependent diabetes
RxNorm normalized name: Diabetic Tussin EX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin-dependent diabetes mellitus (IDDM) patients
Trial: 31956723
Drug: Cognitive-behavior therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavior therapy (CBT)
Trial: 30498987
Drug: Cognitive-behavior therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavior therapy (CBT) or Dialectical-behavior therapy (DBT)
Trial: 25377933
Drug: MK-3207 (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-3207 (20 mg dose)
Trial: 25377933
Drug: MK-3207 (40-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MK-3207 (40-100 mg dose)
Trial: 25377933
Drug: CGRP receptor
RxNorm normalized name: CGRP
DrugBank: Calcitonin gene-related peptide (DB06379)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CGRP receptor antagonists
Trial: 23728118
Drug: Prescription chart
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prescription chart design from NHS Highland
Trial: 23728118
Drug: Prescription chart
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prescription chart design from NHS Grampian
Trial: 23728118
Drug: Other three
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other three prescription chart designs
Trial: 23728118
Drug: Time taken
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Time taken to complete prescriptions
Trial: 16171630
Drug: IA tramadol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IA tramadol 50 mg
Trial: 10421669
Drug: Consensus interferon
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Consensus interferon (CIFN) 15 mcg for 12 months
Trial: 10421669
Drug: Initial interferon
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initial interferon treatment (either 9 mcg CIFN or 3 MU IFN-alpha2b 3 times per week)
Trial: 30678465
Drug: n3PUFA (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n3PUFA (4 g/d)
Trial: 2026848
Drug: High-dose intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose intravenous immunoglobulin (IVIG)
Trial: 9725477
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg ipriflavone tablets three times daily
Trial: 9725477
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg Scherer capsules twice daily
Trial: 7975835
Drug: Booster vaccine
RxNorm normalized name: Moderna COVID-19 (6y+) Bivalent Booster Vaccine PF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Booster vaccine (5 infants)
Trial: 7975835
Drug: One-dose vaccine
RxNorm normalized name: Next Choice One Dose
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: One-dose vaccine (18 infants)
Trial: 2658898
Drug: Subcutaneous porcine
RxNorm normalized name: Secretin porcine
DrugBank: Secretin porcine (DB09527)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous porcine intestinal mucosal heparin
Trial: 2658898
Drug: Porcine intestinal
RxNorm normalized name: porcine intestine preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Porcine intestinal mucosal heparin (both routes)
Trial: 4976123
Drug: Trasicor (beta-adrenergic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trasicor (beta-adrenergic blocking drug)
Trial: 31285738
Drug: Single strain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single strain probiotics, once daily for fourteen days
Trial: 24601169
Drug: 7-day therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-day therapy with omeprazole (20 mg b.i.d.), levofloxacin (500 mg o.i.d.), and amoxicilline (1000 mg b.i.d.)
Trial: 24601169
Drug: 10-day therapy
RxNorm normalized name: tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 10-day therapy with omeprazole (20 mg b.i.d.), levofloxacin (500 mg o.i.d.), and amoxicilline (1000 mg b.i.d.)
Trial: 24601169
Drug: Both 7-day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both 7-day and 10-day therapies
Trial: 15261932
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg irbesartan (IRB)
Trial: 15261932
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg enalapril (ENAL)
Trial: 11600825
Drug: Nelfinavir 750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nelfinavir 750 mg tid + ZDV 200 mg tid + 3TC 150 mg bid
Trial: 11600825
Drug: Nelfinavir 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nelfinavir 500 mg tid + ZDV 200 mg tid + 3TC 150 mg bid
Trial: 11600825
Drug: ZDV 200
RxNorm normalized name: ZDV
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ZDV 200 mg tid + 3TC 150 mg bid + placebo
Trial: 9636854
Drug: Sparfloxacin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sparfloxacin (200 mg once daily following a 400 mg loading dose on day 1)
Trial: 9636854
Drug: Amoxicillin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin (1 g oral dose three times daily)
Trial: 8601365
Drug: ursodiol, 1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ursodiol, 1200 mg/day
Trial: 19137905
Drug: Estomine‐zee (escitalopram
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estomine‐zee (escitalopram oxalate 10 mg and clonazepam 0.5 mg)
Trial: 19137905
Drug: Commercially available
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Commercially available formulation (escitalopram oxalate 10 mg and clonazepam 0.5 mg)
Trial: 30987852
Drug: RSV F
RxNorm normalized name: Respiratory syncytial virus fusion protein.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RSV F subunit vaccine with aluminum hydroxide adjuvant
Trial: 30987852
Drug: RSV F
RxNorm normalized name: Respiratory syncytial virus fusion protein.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RSV F subunit vaccine with MF59 adjuvant
Trial: 14685005
Drug: Pimagedine 150
RxNorm normalized name: pimagedine
DrugBank: Pimagedine (DB05383)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pimagedine 150 mg
Trial: 14685005
Drug: Pimagedine 300
RxNorm normalized name: pimagedine
DrugBank: Pimagedine (DB05383)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pimagedine 300 mg
Trial: 14685005
Drug: Pimagedine (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pimagedine (both doses)
Trial: 15163329
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg MMI
Trial: 28557652
Drug: Clomiphene Citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene Citrate (CC)
Trial: 29426811
Drug: Excision with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Excision with corticosteroid injections
Trial: 24750284
Drug: Pasireotide 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pasireotide 300 μg s.c. t.i.d.
Trial: 16417414
Drug: Sex hormone-binding
RxNorm normalized name: Testosterone bound to sex hormone-binding globulin (SHBG)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sex hormone-binding globulin (SHBG)
Trial: 11302008
Drug: Berry group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Berry group (100 g of deep-frozen berries daily for 8 weeks)
Trial: 11302008
Drug: Supplement group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplement group (100 mg of alpha-tocopherol and 500 mg of ascorbic acid daily)
Trial: 1425135
Drug: Oral Acyclovir
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral Acyclovir
Trial: 30478992
Drug: Fasting glucose
RxNorm normalized name: FAST TAKE (GLUCOSE) METER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fasting glucose levels categorized as <6.1 mmol/l (reference), 6.1-7.0 mmol/l (2nd), ≥7.0 mmol/l (3rd)
Trial: 30439313
Drug: Ordinary flow
RxNorm normalized name: ordinary salt combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ordinary flow device and warm and humid exchanger (artificial nose, HME) passive humid oxygen therapy
Trial: 26252574
Drug: D-mix (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-mix (3 g/dose)
Trial: 12684289
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy alone (Control)
Trial: 15800664
Drug: Candesartan-based antihypertensive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan-based antihypertensive treatment
Trial: 11916549
Drug: Conventional fractionation
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional fractionation (CF) with 70 Gy in 7 weeks, 2 Gy per fraction, daily dose of 6 mg/m² cisplatin
Trial: 11916549
Drug: Modified fractionation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified fractionation (MFD) with three fractions of 1.6 Gy per day, daily dose of 10 mg/m² cisplatin
Trial: 345489
Drug: LH-RH in
RxNorm normalized name: LH
DrugBank: Luteinizing hormone (DB14741)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LH-RH in combination with human menopausal gonadotrophins (HMG)
Trial: 25670361
Drug: 100 g
RxNorm normalized name: Berri-Freez 4.5 GM per 100 GM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 g of almonds daily for 4 weeks
Trial: 23302220
Drug: Mesalazine (2g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mesalazine (2g granules taken up to twice a day for 12 weeks)
Trial: 23302220
Drug: Placebo granule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo granule formulation
Trial: 21530092
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy/Motivational Enhancement Therapy (CBT/MET)
Trial: 21530092
Drug: Naturalistic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naturalistic treatment (Control)
Trial: 19233049
Drug: Methotrexate and
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate and other disease-modifying anti-rheumatic drugs (DMARDs)
Trial: 12638400
Drug: Ketoprofen 75
RxNorm normalized name: ketoprofen 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen 75 mg qid for 3 days
Trial: 12953342
Drug: Acetaminophen 1000
RxNorm normalized name: acetaminophen 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen 1000 mg qid for 3 days
Trial: 19682321
Drug: Ziconotide (in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ziconotide (in combination with other IT agents)
Trial: 8302193
Drug: Flunitrazepam (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunitrazepam (1 mg)
Trial: 1982881
Drug: Quazepam (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quazepam (15 mg)
Trial: 11641942
Drug: Epifamine (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epifamine (400 mg course dose)
Trial: 15328675
Drug: Azelastine nasal
RxNorm normalized name: azelastine nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azelastine nasal spray, 2 sprays per nostril twice daily plus fexofenadine, 60 mg twice daily
Trial: 15328675
Drug: Placebo (saline)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (saline) nasal spray and placebo capsules twice daily
Trial: 9301445
Drug: Cisplatin (CDDP)
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin (CDDP) 100 mg/m2 combined with 5-fluorouracil (5-FU) 1000 mg/m2 continuous infusion from days 1-5 (Arm A)
Trial: 29505101
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg JNJ-54861911 once daily for 7 days
Trial: 29505101
Drug: 90 mg
RxNorm normalized name: papain 90 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90 mg JNJ-54861911 once daily for 7 days
Trial: 29505101
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg JNJ-54861911
Trial: 27807925
Drug: Topiramate 75
RxNorm normalized name: Topiramate
DrugBank: Topiramate (DB00273)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Topiramate 75 mg/day
Trial: 25010303
Drug: Tamsulosin 0.4
RxNorm normalized name: tamsulosin 0.4 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.4 mg plus sildenafil 50 mg
Trial: 25010303
Drug: Tamsulosin 0.4
RxNorm normalized name: tamsulosin 0.4 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.4 mg plus placebo
Trial: 18367288
Drug: Thoracic radiotherapy
RxNorm normalized name: Thoracol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thoracic radiotherapy (TRT) with a planned dose of 50Gy in 2Gy daily fractions, initiated with the fourth chemotherapy cycle.
Trial: 22036029
Drug: 0.1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg/kg body weight
Trial: 22036029
Drug: 0.25 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg/kg body weight
Trial: 22036029
Drug: 0.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/kg body weight
Trial: 16088265
Drug: Mind-body therapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mind-body therapy (structured 60-hour training program over 10 weeks including stress management training, moderate exercise, Mediterranean diet, behavioral techniques and self-care strategies)
Trial: 30260396
Drug: Oral glucose
RxNorm normalized name: glucose Oral Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral glucose tolerance test
Trial: 134722
Drug: Atropine sulphate
RxNorm normalized name: Atropine sulphate
DrugBank: Atropine (DB00572)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atropine sulphate by inhalation (1.6 mg and 2.4 mg)
Trial: 134722
Drug: Atropine sulphate
RxNorm normalized name: Atropine sulphate
DrugBank: Atropine (DB00572)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atropine sulphate by inhalation
Trial: 134722
Drug: Ipratropiumbromide by
RxNorm normalized name: By Ache
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ipratropiumbromide by inhalation
Trial: 11454180
Drug: IFN 4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN 4.5 MU daily plus amantadine 200 mg/day for 4 weeks and then IFN 6 MU thrice weekly plus amantadine 200 mg/day for an additional 5 months (group A)
Trial: 11454180
Drug: IFN alone
RxNorm normalized name: IFNγ
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN alone at the same dosage and duration (group B)
Trial: 26964861
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (Trendelenburg position)
Trial: 24617731
Drug: Intracoronary infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary infusion with bone marrow‐derived mononuclear cells (BMMCs)
Trial: 24617731
Drug: Intracoronary infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary infusion with peripheral blood‐derived mononuclear cells (PBMCs)
Trial: 22137804
Drug: Liberal blood
RxNorm normalized name: dragon's blood extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liberal blood glucose strategy (121‐180 mg/dL)
Trial: 22137804
Drug: Strict blood
RxNorm normalized name: dragon's blood extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Strict blood glucose strategy (90‐120 mg/dL)
Trial: 12628944
Drug: Roxithromycin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roxithromycin (300 mg daily for 6 weeks)
Trial: 24802769
Drug: Adaptive compression
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adaptive compression therapy (ACT) system
Trial: 25191981
Drug: ATP infusion
RxNorm normalized name: ATP
DrugBank: ATP (DB00171)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ATP infusion (100 μg/kg/min)
Trial: 17217450
Drug: NK-1 receptor
RxNorm normalized name: Interleukin-1 receptor antagonist anakinra
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: NK-1 receptor antagonist (NK-1RA)
Trial: 9884136
Drug: Placebo beverages
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo beverages (1 ml alcohol)
Trial: 9884136
Drug: 0.35 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.35 g/kg of alcohol beverages
Trial: 7481209
Drug: No adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No adjuvant systemic therapy (control)
Trial: 2650582
Drug: Quinapril (20-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinapril (20-80 mg/day)
Trial: 2650582
Drug: Captopril (50-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (50-200 mg/day)
Trial: 21991732
Drug: Meperidine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meperidine (1 mg/kg)
Trial: 352484
Drug: Thiopentone (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopentone (2.5 mg/sec)
Trial: 28503725
Drug: Extraction treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extraction treatment with fixed appliances for a mean period of 2.49 years
Trial: 21321613
Drug: Oral rinse
RxNorm normalized name: Oral Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral rinse of Turkish gall